⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
🇬🇧
💊 Medicine AT June 17, 2026

Aprepitant ratiopharm 125 mg Hartkapseln 125 mg (Hartkapsel)

📷 Wikipedia: Aprepitant · Source
Aprepitant ratiopharm 125 mg Hartkapseln 125 mg (Hartkapsel)
📷 Wikipedia: Aprepitant · Source
Aprepitant ratiopharm 125 mg hard capsules are currently unavailable due to a delay in supply. Parallel export is prohibited.
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 86 days ago.
📈 Timeline
48 days in total
June 18, 2026 August 5, 2026

What is this? Aprepitant is a medicine used to stop nausea and vomiting, often after chemotherapy.

What's happening? The supply of Aprepitant ratiopharm 125 mg capsules is delayed. They are not available right now.

Does this affect me? If you take this medicine, you may have trouble getting it.

What should I do? Talk to your pharmacist or doctor about other options.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: A04AD12 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 5 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-06-15]

First published
June 17, 2026
Last refreshed by us
1 month ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Aprepitant ratiopharm 125 mg Hartkapseln 125 mg (Hartkapsel). Aprepitant ratiopharm 125 mg hard capsules are currently unavailable due to a delay in supply. Parallel export is prohibited.
When was this alert issued?
This alert was issued on June 17, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.